Abstract
Several Ru-arene and Ir-Cp* complexes have been prepared incorporating (N,N), (N,O) and (O,O) coordinating bidentate ligands and have been found to be active against both HT-29 and MCF-7 cell lines. By incorporating a biologically active ligand into a metal complex the anti-cancer activity is increased.
| Original language | English |
|---|---|
| Pages (from-to) | 13800-13802 |
| Number of pages | 3 |
| Journal | Dalton Transactions |
| Volume | 41 |
| Issue number | 45 |
| Early online date | 14 Sep 2012 |
| DOIs | |
| Publication status | Published - 7 Dec 2012 |
| Externally published | Yes |
Fingerprint Dive into the research topics of 'Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents'. Together they form a unique fingerprint.
Cite this
Lucas, S. J., Lord, R. M., Wilson, R. L., Phillips, R. M., Sridharan, V., & McGowan, P. C. (2012). Synthesis of iridium and ruthenium complexes with (N,N), (N,O) and (O,O) coordinating bidentate ligands as potential anti-cancer agents. Dalton Transactions, 41(45), 13800-13802. https://doi.org/10.1039/c2dt32104a